“5-Bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one targets prostate cancer cells by down-regulating inflammation-related genes”, Bangladesh J Pharmacol, vol. 11, no. 2, pp. 408–413, Mar. 2016, doi: 10.3329/bjp.v11i2.23872.